ENLV

1.05010.26%
OH

Oren Hershkovitz

Chief Executive Officer

Dr. Oren Hershkovitz, Ph.D. serves as Chief Executive Officer at Enlivex Therapeutics Ltd. since November 16, 2019. Dr. Hershkovitz served for nearly a decade in managerial and executive roles at PROLOR Biotech, Inc. and OPKO Biologics, Ltd., the biotech subsidiary of OPKO Health, Inc. acting as General Manager of OPKO Biologics for the past four years. Dr. Hershkovitz successfully managed more than 70 employees and led manufacturing, non-clinical and clinical development for various Phase I, II and III programs, including for obesity, hemophilia and growth hormone deficiency. Dr. Hershkovitz obtained his Ph.D. in immunology, with distinction, from Ben Gurion University in Israel.

Positions